Catalyst Wire Dossier Catalyst Wire Dossier

RC017 Ophthalmic Ointment

RC017 · Nanjing Reju Therapeutics Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RC017 Ophthalmic Ointment, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of RC017 Ophthalmic Ointment Following Single and Multiple Doses in Healthy Adult Participants [Phase 1]

See pricing